NORAKER

NORAKER is a French biotechnology company established in 2005, specializing in the design, manufacturing, and marketing of synthetic, absorbable biomaterial-based implantable medical devices. Their primary focus is on bone regeneration and osteosynthesis, utilizing bioactive glass technology, particularly Bioactive Glass 45S5, to promote bone healing across various medical fields. The company's product range supports multiple surgical specialties, including orthopaedic surgery, dental surgery, and sports medicine. NORAKER's implants are designed to enhance patient comfort and clinical outcomes by facilitating better bone regeneration and minimizing the need for secondary surgeries. They maintain high-quality standards, holding NF EN ISO 13485:2004 certification and CE marking for all products. NORAKER is dedicated to innovation and collaborates closely with healthcare professionals, academic institutions, and industrial partners. A notable achievement includes the development of a bioactive composite fixation implant that combines an absorbable polymer with bioactive glass, recognized for its superior bone regeneration performance. The company aims to improve patient care and quality of life through advanced biomaterials and regenerative medicine technologies.

• Employees 30
• Founded 2005